Physician profile
Howard N Murray
NPI 1972633303
$1,262.49
in general payments reported to CMS, 2019-2025
12 companies · $14.70 in 2025
The $14.70 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $213 · 2021: $329 · 2022: $342 · 2023: $208 · 2024: $51.69 · 2025: $14.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $443.90 | 2020-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $327.19 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.39 | 2019-2022 | |
| Insmed, INC. | $100.19 | 2020-2024 | Arikayce |
| Baxter Healthcare | $61.92 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Mylan Specialty L.P. | $47.07 | 2019-2023 | Yupelri |
| Inogen, INC. | $40.97 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Janssen Pharmaceuticals, INC | $40.38 | 2023 | Xarelto |
| Sunovion Pharmaceuticals INC. | $31.70 | 2019 | |
| Grifols USA, LLC | $17.35 | 2022 | |
| Philips North America LLC | $14.70 | 2025 | Lm Undivided |
| Electromed, INC. | $13.73 | 2024 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.